Published in J Biol Chem on February 15, 1992
Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. Nat Chem Biol (2009) 1.65
Existence of distinct tyrosylprotein sulfotransferase genes: molecular characterization of tyrosylprotein sulfotransferase-2. Proc Natl Acad Sci U S A (1998) 1.51
Analysis of sequence requirements for protein tyrosine sulfation. Protein Sci (1993) 0.92
CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain. J Virol (2001) 0.91
Tyrosine O-sulfation promotes proteolytic processing of progastrin. EMBO J (1995) 0.86
A common African polymorphism abolishes tyrosine sulfation of human anionic trypsinogen (PRSS2). Biochem J (2009) 0.84
Pattern and temporal sequence of sulfation of CCR5 N-terminal peptides by tyrosylprotein sulfotransferase-2: an assessment of the effects of N-terminal residues. Biochemistry (2009) 0.83
Crystal structure of human tyrosylprotein sulfotransferase-2 reveals the mechanism of protein tyrosine sulfation reaction. Nat Commun (2013) 0.81
Identification and characterization of tyrosylprotein sulfotransferase from human saliva. Int J Biol Sci (2005) 0.79
Tyrosine sulfation of statherin. Int J Biol Sci (2007) 0.79
Synthesis of Sulfotyrosine-Containing Peptides by Incorporating Fluorosulfated Tyrosine Using an Fmoc-Based Solid-Phase Strategy. Angew Chem Int Ed Engl (2015) 0.76
Structural and energetic determinants of tyrosylprotein sulfotransferase sulfation specificity. Bioinformatics (2014) 0.75
Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet (1998) 7.70
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health (2006) 6.43
VT/VF: 60/60 protection. Pacing Clin Electrophysiol (1990) 5.15
Reactive pseudosarcomatous response in urinary bladder. Urology (1980) 2.89
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg (2000) 2.88
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol (1995) 2.62
Creatinine assay by a reaction-kinetic principle. Clin Chim Acta (1972) 2.26
Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg (1995) 2.25
The effect of a stroke unit: reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. Stroke (1995) 2.23
Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol (1994) 2.19
Survival in early-stage non-small cell lung cancer. Ann Thorac Surg (1995) 2.01
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med (1983) 1.99
Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.97
Radiation therapy following resection of non-small cell bronchogenic carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.93
Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol Cell Biol (2000) 1.93
Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res (2001) 1.91
The assessment of postoperative cognitive function. Acta Anaesthesiol Scand (2001) 1.90
Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J Natl Cancer Inst (1994) 1.83
Central visual field in diabetes. Br J Ophthalmol (1969) 1.83
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg (2000) 1.83
Specificity, stereochemistry, and mechanism of the color reaction between p-dimethylaminocinnamalhyde and biotin analogs. Anal Biochem (1970) 1.82
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. Ann Surg Oncol (1998) 1.78
Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res (1999) 1.78
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol (1998) 1.76
Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol (2002) 1.68
Neutrophil activation by recombinant cytokines. Rev Infect Dis (1989) 1.63
Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res (1994) 1.59
Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest (1992) 1.59
Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care (2000) 1.56
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst (2001) 1.55
Benefits of implantable defibrillators are overestimated by sudden death rates and better represented by the total arrhythmic death rate. J Am Coll Cardiol (1991) 1.53
Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg (1992) 1.49
Synovial sarcoma of the neck: a followup study of 24 cases. Cancer (1975) 1.48
p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res (1991) 1.48
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst (1999) 1.47
Crystal structures at 2.5 angstrom resolution of seryl-tRNA synthetase complexed with two analogs of seryl adenylate. Science (1994) 1.47
Peak selection from MALDI-TOF mass spectra using ant colony optimization. Bioinformatics (2007) 1.44
Possible association of thymus dysfunction with fading syndromes in puppies and kittens. Vet Clin North Am Small Anim Pract (1987) 1.44
Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res (1993) 1.43
Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol (1993) 1.42
The psychosocial M & M: a tool in reinterpreting problematic medical situations. Fam Med (1991) 1.42
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys (1995) 1.40
Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. Ann Intern Med (1992) 1.39
Release of 5'-guanosine monophosphate and adenine by Brucella abortus and their role in the intracellular survival of the bacteria. J Infect Dis (1986) 1.39
Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer (1989) 1.38
Who benefits from treatment and rehabilitation in a stroke Unit? A community-based study. Stroke (2000) 1.38
Use of complementary and alternative treatment for allergic contact dermatitis. Br J Dermatol (2007) 1.38
Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. Cancer Res (2000) 1.37
Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol Med (2001) 1.37
Improved survival after resection of pulmonary metastases from malignant melanoma. Ann Thorac Surg (1991) 1.31
Influenza virus M1 protein binds to RNA through its nuclear localization signal. J Gen Virol (1997) 1.31
Some contingencies of the moral evaluation and control of clientele: the case of the hospital emergency service. AJS (1972) 1.30
Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma. Oncogene (1995) 1.30
Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res (1998) 1.29
Non-reflex and reflex mediated ankle joint stiffness in multiple sclerosis patients with spasticity. Muscle Nerve (1993) 1.28
Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer (1992) 1.28
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol (1993) 1.28
Evaluation of bovine polymorphonuclear leukocyte function. Vet Immunol Immunopathol (1981) 1.27
Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res (1989) 1.24
Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene (2001) 1.22
Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene Ther (2000) 1.22
Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res (1996) 1.21
Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol (1990) 1.20
Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin Cancer Res (2001) 1.20
Guanethidine and adrenaline used in combination in chronic simple glaucoma. Br J Ophthalmol (1973) 1.19
A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections. J Thorac Cardiovasc Surg (2001) 1.19
Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection. Vet Pathol (2000) 1.18
Analysis of prognostic factors in patients undergoing resection of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg (1984) 1.18
Reoperative pulmonary resection in patients with metastatic soft tissue sarcoma. Ann Thorac Surg (1991) 1.18
Host repopulation of endothelium. Transplant Proc (1971) 1.16
Cell-mediated immunity is depressed following cardiopulmonary bypass. Ann Thorac Surg (1981) 1.16
Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells. Gene Ther (1998) 1.16
Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res (1994) 1.15
Carcinoma arising in an ileostomy stoma: an unusual complication of adenomatous polyposis coli. Cancer (1982) 1.15
Liver biopsy in Hodgkin's disease. Clinicopathologic correlations in 127 patients. Ann Intern Med (1972) 1.15
Oxygen regulation of uricase and sucrose synthase synthesis in soybean callus tissue is exerted at the mRNA level. Plant Mol Biol (1991) 1.15
Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: analysis of prognostic factors. Ann Thorac Surg (1983) 1.15
Lack of correlation between skin reactivity to dinitrochlorobenzene and croton oil in patients with cancer. N Engl J Med (1975) 1.14
Mechanical and electromyographic responses to stretch of the human ankle extensors. J Neurophysiol (1991) 1.14
Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol Carcinog (1996) 1.13
Marked increase of stroke incidence in men between 1972 and 1990 in Frederiksberg, Denmark. Stroke (1992) 1.13
Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis (1995) 1.13
Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study. Breast Cancer Res Treat (1985) 1.13
Activation of bovine neutrophils by recombinant interferon-gamma. Cell Immunol (1986) 1.13
A rapid, direct assay to measure degranulation of bovine neutrophil primary granules. Vet Immunol Immunopathol (1997) 1.12
Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Vet Pathol (2012) 1.12
Preferential inhibition of primary granule release from bovine neutrophils by a Brucella abortus extract. Infect Immun (1986) 1.12
Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery. J Biol Chem (1998) 1.12
An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53. Gene Ther (2002) 1.11
Inadequate diagnostic value of the water-drinking test. Br J Ophthalmol (1974) 1.11
Characterization of early pathogenic effects after experimental infection of calves with bovine immunodeficiency-like virus. J Virol (1992) 1.11
Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor. Eur J Clin Microbiol Infect Dis (2008) 1.11
Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells. Oncogene (2000) 1.10
Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res (1991) 1.09
Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids. Cytobios (1987) 1.09
Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma. Proc Natl Acad Sci U S A (1986) 1.09
Effects of bovine viral diarrhea virus infection on bovine polymorphonuclear leukocyte function. Am J Vet Res (1981) 1.09
Pulmonary disposition of circulating vasoactive hormones. Biochem Pharmacol (1976) 1.09